Call for Adoption of Synchronized Biweekly Dosing of Anti-EGFR Agent Cetuximab: Implications for Patients with Metastatic Colorectal Cancer, and Squamous Cell Carcinoma of the Head and Neck

被引：2
|
作者：
Kasi, Pashtoon Murtaza [1 ]
机构：
[1] Weill Cornell Med, Meyer Canc Ctr, Englander Inst Precis Med, 1305 York Ave, New York, NY 10021 USA
来源：
ONCOLOGIST | 2022年 / 27卷 / 05期
关键词：
D O I：
10.1093/oncolo/oyac070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：336 / 337
页数：2
相关论文
共 50 条
  • [31] Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance
    Troiani, Teresa
    Zappavigna, Silvia
    Martinelli, Erika
    Addeo, Santolo R.
    Stiuso, Paola
    Ciardiello, Fortunato
    Caraglia, Michele
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 241 - 255
  • [32] Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI
    Yonesaka, Kimio
    Tanaka, Kaoru
    Kitano, Mutsukazu
    Kawakami, Hisato
    Hayashi, Hidetoshi
    Takeda, Masayuki
    Sakai, Kazuko
    Nishio, Kazuto
    Doi, Katsumi
    Nakagawa, Kazuhiko
    ONCOGENESIS, 2019, 8 (10)
  • [33] Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI
    Kimio Yonesaka
    Kaoru Tanaka
    Mutsukazu Kitano
    Hisato Kawakami
    Hidetoshi Hayashi
    Masayuki Takeda
    Kazuko Sakai
    Kazuto Nishio
    Katsumi Doi
    Kazuhiko Nakagawa
    Oncogenesis, 8
  • [34] ANALYSIS OF 16 PATIENTS WITH METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - IMPLICATIONS FOR TREATMENT
    BENASSO, M
    FERRO, A
    BACIGALUPO, A
    TOMA, S
    VITRIOLO, S
    ROSSO, R
    MERLANO, M
    TUMORI, 1989, 75 (06) : 597 - 599
  • [35] Progression-free survival (PFS) as a measure of efficacy for anti-EGFR antibodies in recurrent/metastatic (R/M) squamous cell carcinoma of head and neck (SCCHN).
    Misiukiewicz, Krzysztof
    Winder, Lewis
    Parides, Michael
    Bonomi, Marcelo Raul
    Posner, Marshall R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Affinity of yttrium-90 labeled anti-EGFR antibody cetuximab to head and neck squamous cell carcinoma (HNSCC) xenografts, compared to the response to combined external and internal irradiation
    Sihver, Wiebke
    Koi, Lydia
    Bruechner, Kerstin
    Heldt, Jan-Martin
    Bergmann, Ralf
    Pietzsch, Hans-Juergen
    Pietzsch, Jens
    Steinbach, Joerg
    Zips, Daniel
    Baumann, Michael
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S41 - S41
  • [37] Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa
    Yang, Chuan-Chien
    Lien, Ching-Feng
    Hwang, Tzer-Zen
    Wang, Chih-Chun
    Wang, Chien-Chung
    Shih, Yu-Chen
    Yeh, Shyh-An
    Hsieh, Meng-Che
    CANCERS, 2022, 14 (10)
  • [38] Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck
    Goksu, Sema Sezgin
    Tatli, Ali Murat
    Geredeli, Caglayan
    Atci, Mustafa
    Besen, Ali Ayberk
    Mertsoylu, Huseyin
    Uysal, Mukremin
    Ozdogan, Mustafa
    Aydin, Sabin Goktas
    Bilici, Ahmet
    Karaagac, Mustafa
    Artac, Mehmet
    Kaplan, Muhammet Ali
    Ebinc, Senar
    Coskun, Hasan Senol
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (05) : 805 - 812
  • [39] Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients
    Sukari, Ammar
    Nagasaka, Misako
    Diab, Maria
    Al Sibai, Khaled
    Atassi, Bassel
    Elayoubi, Jailan A.
    Kim, Seongho
    Kucuk, Omer
    CLINICAL OTOLARYNGOLOGY, 2019, 44 (04) : 639 - 643
  • [40] Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck
    Sema Sezgin Göksu
    Ali Murat Tatlı
    Çağlayan Geredeli
    Mustafa Atcı
    Ali Ayberk Besen
    Hüseyin Mertsoylu
    Mükremin Uysal
    Mustafa Özdoğan
    Sabin Göktaş Aydın
    Ahmet Bilici
    Mustafa Karaağaç
    Mehmet Artaç
    Muhammet Ali Kaplan
    Senar Ebinç
    Hasan Şenol Coşkun
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 805 - 812
12345